Found 0 matching trials
Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors PHASE1 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Children's Hospital Los Angeles
Learn More & Join Trial
Haploidentical Lymphocytes With Nivolumab/Ara-C as Consolidation in Elderly AML Patients PHASE2 A phase II trial to compare the efficacy and safety of nivolumab and interm...
Show More Location
Boris V Afanasyev, MD, Prof.
Learn More & Join Trial
High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies PHASE1 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Show More Location
Massey Cancer Center
Learn More & Join Trial
BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients PHASE3 T-cell acute lymphoblastic leukemia (T-ALL), a hematological malignant neop...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Safety Study of Thioridazine in Combination With Cytarabine to Treat Relapsed or Refractory Acute Myeloid Leukemia PHASE1 This is a Phase I trial investigating the safety of using thioridazine in a...
Show More Location
Juravinski Hospital & Cancer Centre
Learn More & Join Trial
Phase II Trial of Alisertib With Induction Chemotherapy in High-risk AML PHASE2 This research study is studying a targeted therapy (a form of treatment tha...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Escalation of Doses of Daratumumab in Combination With Chemotherapy (Idarubicin and Cytarabine or CPX-351) in Patients of 60 Years Old or More With Adverse Risk Acute Myeloblastic Leukemia (AML) (DARALAM) PHASE1 To search for a Maximum Tolerated Dose (MTD) for the combination of daratum...
Show More Learn More & Join Trial
Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia PHASE3 To confirm the efficacy of CPX-351 compared to 7+3 as first line therapy in...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia PHASE2 The overall aim of this study is to determine if epigenetic priming with a ...
Show More Status
Active Not Recruiting
Location
Children's Hospital of Central California
Learn More & Join Trial
Velcaflagida in Relapsed or Refractary Acute Myeloid Leukemia PHASE1 The primary aim of this study is:
• To analyze the efficacy (in order to e...
Show More Location
Hospital Universitario de Salamanca
Learn More & Join Trial